Magnus Lindh1, Charles Hannoun. 1. Department of Clinical Virology, Guldhedsgatan 10 B, 413 46 Göteborg, Sweden. magnus.lindh@microbio.gu.se
Abstract
BACKGROUND: Genotype of hepatitis C virus (HCV) is of major importance for the outcome of treatment. The response rate is considerably lower for genotype 1, the predominant genotype in western countries. OBJECTIVES: To develop and evaluate a new, simple method for genotyping of HCV based on real-time polymerase chain reaction (PCR) and Taqman probes targeting the 5' non-coding region. STUDY DESIGN: The method was compared with Innolipa on 220 serum samples representing genotypes 1-4, and was applied on a further 614 clinical samples. RESULTS: Taqman typing of the 220 samples showed genotype 1 in 69, genotype 2 in 58, genotype 3 in 57 and genotype 4 in 19, while 17 were non-reactive. There was a complete concordance with Innolipa with the exception of seven samples, which were of genotype 1 by Taqman, but genotype 4 by Innolipa. Sequencing of these samples showed a subtype 4 variant which differed at two positions compared with subtypes 4b/c/d, which are targeted by the probe. By adding a modified probe, these genotype 4 variants could also be identified. Out of 614 consecutive clinical samples, 524 could be typed by the Taqman assay; 45.2% were genotype 1, 19.3% genotype 2, 33.8% genotype 3 and 1.7%, genotype 4. CONCLUSION: The method was overall accurate and provides an attractive alternative for genotyping because processing time and costs are significantly reduced. Inclusion of probes targeting genotypes 5 and 6 is required for the method to be useful in areas where these genotypes are present.
BACKGROUND: Genotype of hepatitis C virus (HCV) is of major importance for the outcome of treatment. The response rate is considerably lower for genotype 1, the predominant genotype in western countries. OBJECTIVES: To develop and evaluate a new, simple method for genotyping of HCV based on real-time polymerase chain reaction (PCR) and Taqman probes targeting the 5' non-coding region. STUDY DESIGN: The method was compared with Innolipa on 220 serum samples representing genotypes 1-4, and was applied on a further 614 clinical samples. RESULTS: Taqman typing of the 220 samples showed genotype 1 in 69, genotype 2 in 58, genotype 3 in 57 and genotype 4 in 19, while 17 were non-reactive. There was a complete concordance with Innolipa with the exception of seven samples, which were of genotype 1 by Taqman, but genotype 4 by Innolipa. Sequencing of these samples showed a subtype 4 variant which differed at two positions compared with subtypes 4b/c/d, which are targeted by the probe. By adding a modified probe, these genotype 4 variants could also be identified. Out of 614 consecutive clinical samples, 524 could be typed by the Taqman assay; 45.2% were genotype 1, 19.3% genotype 2, 33.8% genotype 3 and 1.7%, genotype 4. CONCLUSION: The method was overall accurate and provides an attractive alternative for genotyping because processing time and costs are significantly reduced. Inclusion of probes targeting genotypes 5 and 6 is required for the method to be useful in areas where these genotypes are present.
Authors: Linda Cook; KaWing Sullivan; Elizabeth M Krantz; Arthur Bagabag; Keith R Jerome Journal: J Clin Microbiol Date: 2006-09-20 Impact factor: 5.948
Authors: Sueli M Nakatani; Carlos A Santos; Irina N Riediger; Marco A Krieger; Cesar A B Duarte; Marco A Lacerda; Alexander W Biondo; Flair J Carrilho; Flair J Carilho; Suzane K Ono-Nita Journal: PLoS One Date: 2010-04-13 Impact factor: 3.240
Authors: Magnus Lindh; Erik Alestig; Birgitta Arnholm; Anders Eilard; Kristoffer Hellstrand; Martin Lagging; Thomas Wahlberg; Rune Wejstål; Johan Westin; Gunnar Norkrans Journal: J Clin Microbiol Date: 2007-06-20 Impact factor: 5.948
Authors: Jonas Söderholm; Jesper Waldenström; Galia Askarieh; Massimo Pilli; Pierre-Yves Bochud; Francesco Negro; Jean-Michel Pawlotsky; Stefan Zeuzem; Carlo Ferrari; Gunnar Norkrans; Rune Wejstål; Johan Westin; Avidan U Neumann; Bart L Haagmans; Magnus Lindh; Gabriele Missale; Kristoffer Hellstrand; Martin Lagging Journal: PLoS One Date: 2013-02-20 Impact factor: 3.240
Authors: Olav Dalgard; Ola Weiland; Geir Noraberg; Lars Karlsen; Lars Heggelund; Martti Färkkilâ; Ulla Balslev; Erika Belard; Anne Øvrehus; Mette Skalshøi Kjær; Henrik Krarup; Birgit Thorup Røge; Sofie Hallager; Lone G Madsen; Alex Lund Laursen; Martin Lagging; Nina Weis Journal: PLoS One Date: 2017-07-13 Impact factor: 3.240